A judge has taken ASIC to task for pleading its remitter case against Mayfair 101 Group director James Mawhinney in minute detail, but has rejected arguments the regulator ran the proceeding in an “oppressive and unmeritorious” way.
A judge has ordered ANZ to explain itself after hearing the director of a Gold Coast property developer under investigation withdrew $112,000 from a bank account subject to freezing orders.
Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.
A judge has expressed frustration over the fourth discovery fight this year in Fortescue’s trade secrets case against Element Zero, as the green iron startup claims its bigger rival is trying to drag out the litigation.
An appeals court has thrown out challenges by three mining giants to a Fair Work Commission decision that requires them to bargain together with a group of employees and their union.
Regeneron and Bayer have lost their bid to block generic drug maker Sandoz from launching a biosimilar of their blockbuster eye drug Eylea.
A court has appointed receivers to two entities of collapsed asset manager Australian Fiduciaries amid concerns by the corporate regulator that $167 million in funds have been misused, including to buy $600,000 in luxury cars.
The High Court has been asked to clarify the jurisdictional reach of the Victoria Supreme Court to hear planning disputes, in a spat between the state and supermarket operator IGA.
A judge has hit Mayfair Group director James Mawhinney with 15-year injunctions, after finding he took a “cavalier attitude to compliance” in marketing notes tied to Mission Beach properties in Queensland.
Australia’s most-decorated soldier, Ben Roberts-Smith, has lost his bid for special leave from the High Court to appeal a judge’s findings that he committed war crimes in Afghanistan.